What do systematic reviews say?

6 questions · 6 findings · 3 reviews · Gynaecological, Neuro-oncology and Orphan Cancer

No studies found 6 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Quality of life ‐ not measured · women with recurrent epithelial ovarian cancer

The review found no eligible studies for this question.

1 finding from 1 review

Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life ‐ not measured · women with recurrent epithelial ovarian cancer

The review found no eligible studies for this question.

1 finding from 1 review

Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life: not measured · treatment of relapsed epithelial ovarian cancer

The review found no eligible studies for this question.

1 finding from 1 review

Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Quality of life ‐ not measured · participants with cancer treated with chemotherapy

The review found no eligible studies for this question.

1 finding from 1 review

Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)

The review found no eligible studies for this question.

1 finding from 1 review

Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)

The review found no eligible studies for this question.

1 finding from 1 review